To determine whether trophoblast cell surface antigen 2 (Trop2) is involved in TCO-mediated antitumor effect in lung cancer cells, we firstly examined the expression of Trop2 in TCO-treated cells. This evidence concerns the gene TACSTD2 and lung cancer.